IFRX (InflaRx N.V.) Yalpi foyda bo'yicha marjinallik

IFRX (InflaRx) - kompaniyaning tovar belgisi

InflaRx N.V. (IFRX) kritik yallig'lanish terapiyasi uchun C5a proteinini bloklashga ixtisoslashgan. Valo martaba koeffitsiyenti operatsion samaradorlikni namoyish etadi, 0.00 ko'rsatkichi esa joriy darajani tasdiqlaydi. Kompaniyaning o'sishi Gohibic dori vositasini tijoratlashtirishga va ushbu dori uchun yangi qo'llanish sohalarini izlashga bog'liq. Biroq, geosiyosiy fragmentatsiya va savdo cheklovlari innovatsion ishlanmalarning xalqaro taqsimotiga to'sqinlik qilmoqda.

IFRX: InflaRx Yalpi marja 04.07.2022 - 19.11.2026

InflaRx N.V. (IFRX) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- kotirovkalar va tahlilchilar prognozi:
- biznesning bozor baholash ko'rsatkichlari:
Kompaniyaning jamlanma tahlili:inflarx.de (IFRX)
InflaRx GmbH tomonidan chiqariladigan mahsulotlar

Yalpi foyda marjasi bevosita ishlab chiqarish xarajatlarini chegirib tashlagandan keyin daromadning har bir birligining foyda ulushini aniqlash orqali ishlab chiqarish samaradorligini o'lchaydi. 0.00 darajasidagi yalpi foyda marjasi dinamikasini tahlil qilish orqali investor InflaRx N.V. (IFRX) kompaniyasining intensiv terapiya uchun murakkab dori vositalarini yaratishda yuqori daromadlilikni saqlagan holda, immunologiya va C5a antitanalari sohasidagi o'ziga xos ishlanmalarini monetizatsiya qilish qobiliyatini baholaydi.

Asosiy raqobatchilar

argenx - Yalpi foyda normasi|Yalpi rentabellik biontech.de|ABIVAX (ABVX) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja ADMA|Yalpi foyda koeffitsiyenti PTGX|Yalpi rentabellik Immunovant Corp IMVT|Yalpi marja Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Yalpi foyda bo'yicha rentabellik|Aurinia Pharmaceuticals Inc. (AUPH) - Yalpi marja|Yalpi foyda bo'yicha rentabellik BCRX|Yalpi foyda marjasi Vera Therapeutics Inc VERA|Yalpi foyda bo'yicha rentabellik DNTH (Dianthus Pharma)|Yalpi foyda bo'yicha sotuv rentabelligi Pharvaris N.V.|AbCellera Biologics Inc - Yalpi foyda bo'yicha rentabellik|Tourmaline Bio (TRML) - Yalpi foyda marjasi|PGEN - Yalpi rentabellik|Yalpi foyda normasi PHAR (Pharming Group NV)|NKTR: Yalpi marja|Upstream Bio Corp - Yalpi foyda normasi|Yalpi rentabellik Zenas Biopharma Inc|Immunome, Inc. (IMNM) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja GOSS|Yalpi foyda bo'yicha rentabellik KalVista Pharmaceuticals, Inc. KALV|Yalpi rentabellik Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Yalpi foyda marjasi|SVRA - Yalpi rentabellik|Rigel Pharmaceuticals - Yalpi foyda koeffitsiyenti|AnaptysBio Corp (ANAB) - Yalpi rentabellik|ATXS - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik enGene Holdings Inc.|RAPT: Yalpi foyda normasi|Yalpi marja JBIO|Yalpi foyda bo'yicha rentabellik aclaristx.com ACRS|Yalpi rentabellik Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Yalpi foyda marjasi|Cabaletta Bio, Inc - Yalpi marja|Yalpi foyda marjasi Ventyx Biosciences|THTX (theratech.com) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Yalpi marja|Yalpi foyda marjasi Agenus Inc. AGEN|Yalpi foyda bo'yicha rentabellik CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Yalpi foyda normasi|Yalpi rentabellik atyrpharma.com ATYR|Yalpi marja Adagene Corp ADAG|IMA - Yalpi rentabellik|Yalpi foyda normasi STTK (Shattuck Labs)|EQ: Yalpi marja|Connect Biopharma (CNTB) - Yalpi marja|Yalpi rentabellik Immunic|Yalpi marja atarabio.com|x4pharma.com (XFOR) - Yalpi foyda normasi|Adicet Bio, Inc. - Sotuvning yalpi rentabelligi|Celularity Inc - Yalpi foyda bo'yicha rentabellik|Yalpi marja INmune Bio Corporation INMB|Barinthus Biotherapeutics - Yalpi marja|Kezar Life Sciences, Inc. (KZR) - Yalpi foyda bo'yicha rentabellik|SAB Biotherapeutics Inc. (SABS) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Akari Therapeutics plc|Yalpi rentabellik enlivex.com|q32bio.com (QTTB) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja GOVX|Edesa Biotech, Inc. - Sotuvning yalpi rentabelligi|iBio Inc - Yalpi foyda bo'yicha rentabellik|Yalpi marja Carisma Therapeutics CARM|XTLB - Yalpi rentabellik|BOLT (boltbio.com) - Sotuvning yalpi rentabelligi|HCWB: Yalpi marja|Aptevo (APVO) - Yalpi marja|Yalpi rentabellik AIM ImmunoTech|Yalpi foyda bo'yicha rentabellik Aditxt (ADTX)|Yalpi foyda bo'yicha rentabellik GRI (GRI Bio Corporation)|XORTX - Sotuvning yalpi rentabelligi|Yalpi marja HIND (Vyome Holdings Inc.)|Yalpi foyda normasi REVB|Indaptus - Yalpi marja|SCNI (Scinai Immunotherapeutics Ltd.) - Sotuvning yalpi rentabelligi|CALI: Yalpi marja|Affimed NV - Yalpi foyda normasi|Yalpi rentabellik Allakos Inc.|Yalpi marja HOOKIPA Pharma|Yalpi rentabellik IGM Biosciences, Inc. (IGMS)|ITOS - Yalpi foyda marjasi|Yalpi marja OCEA (Ocean Bio)|Yalpi foyda normasi TCBP|THRD - Yalpi rentabellik